Frontlight ResearchEarly access
Diabetic eye disease trials in China
21 of 29 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in ChinaIIIb Trial for RC28-E Injection in Participants With DME and wAMD
- Where
- Beijing
- Age
- 18 years and over
- People
- 350
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT07936487 - Phase 2Taking peopleA Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Where
- Chengdu, Shanghai, Shenyang, Shijiazhuang, Taiyuan
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06962839 · EU 2024-520384-14-00 - Phase 3Not yet taking people in ChinaA Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
- Where
- Beijing, Changchun, Changsha, Haerbin, Hangzhou, Jinan, Lanzhou, Nanchang, Shanghai, Taiyuan, Taizhou, Tianjin, Weifang, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 514 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07867080 - No phaseNot yet taking people in ChinaA Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,200
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07833228 - Phase 1Not yet taking people in ChinaA Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
- Where
- Shanghai
- Age
- 18 years to 85 years
- People
- 60
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT07817615 - No phaseTaking peopleHome- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT
- Where
- Dongguan, Foshan, Guangzhou
- Age
- 18 years and over
- People
- 308
- Run by
- Zhongshan Ophthalmic Center, Sun Yat-sen University
See details and how to joinNCT06610747 - Phase 4Not yet taking people in ChinaZhuochuming®-3T&E-DME Study (Treatment-naïve Patients)
- Where
- Dalian
- Age
- 18 years and over
- People
- 186
- Run by
- The Third Peoples Hospital of Dalian
See details and how to joinNCT07612904 - No phaseTaking peopleEarly Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
- Where
- Beijing, Dalian, Nanjing, Xiamen, Zhengzhou
- Age
- 18 years and over
- People
- 100
- Run by
- Xiamen Ophthalmology Center Affiliated to Xiamen University
See details and how to joinNCT07586787 - Phase 3Taking peopleEfficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Deyang, Guangzhou, Hangzhou, Jinan, Lanzhou, Luoyang, Nanjing, Nanning, Neimeng, Panjin, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Taizhou, Weifang, Wenzhou, Wuhan, Wuxi, Xi’an, Xianyang, Xingtai, Zhengzhou, Zunyi
- Age
- 18 years to 80 years
- People
- 406
- Run by
- Bio-Thera Solutions
See details and how to joinNCT07515079 - Early phase 1Taking peopleSafety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
- Where
- Shanghai
- Age
- 18 years and over
- People
- 32
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07362927 - No phaseNot yet taking people in ChinaNew Pattern of Retinal Laser Treatment for PDR
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 300
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT07315802 - Phase 1Taking peopleMS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
- Where
- Changsha, Chengdu, Shanghai
- Age
- 18 years and over
- People
- 45
- Run by
- Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
See details and how to joinNCT04187443 - Phase 2Not yet taking people in ChinaMulticenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling
- Where
- Chengdu, Deyang, Guangyuan
- Age
- 18 years to 70 years
- People
- 160
- Run by
- Hejiang Ye
See details and how to joinNCT06813274 - Phase 3Taking peopleClinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
- Where
- Beijing, Dalian, Guangzhou, Guiyang, Hengyang, Jinan, Kaifeng, Kunming, Liaocheng, Luoyang, Luzhou, Panzhihua, Shenzhen, Shijiazhuang, Shiyan, Wuhan, Wuxi, Xi'an, Xi’an, Xianyang, Xinxiang, Xuancheng, Yichang, Zhengzhou, Zhuhai
- Age
- 18 years to 75 years
- People
- 360
- Run by
- Beletalent (Zhuhai) Pharmaceutical Co., Ltd
See details and how to joinNCT06817265 - No phaseTaking peopleRemote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
- Where
- Beijing
- Age
- 40 years to 80 years
- People
- 68
- Run by
- Xuxiang Zhang, MD
See details and how to joinNCT06713720 - No phaseTaking peopleEffect of Video Viewing on Intravitreal Injection Experience
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 182
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07002372 - No phaseNot yet taking people in ChinaInvestigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas in Diabetic Retinopathy Patients
- Where
- Chengdu
- Age
- 18 years and over
- People
- 30
- Run by
- Sichuan Provincial People's Hospital
See details and how to joinNCT06821633 - Phase 3Enrolling by invitationIntravitreal and Intracameral DEX in NPDR
- Where
- Nantong
- People
- 80
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT06951087 - Phase 1/2Taking peopleGene Therapy for DME
- Where
- Tianjin
- Age
- 18 years to 74 years
- People
- 78
- Run by
- Frontera Therapeutics
See details and how to joinNCT06492876 - Early phase 1Taking peopleThe Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)
- Where
- Tianjin
- Age
- 20 years to 80 years
- People
- 6
- Run by
- Li Xiaorong
See details and how to joinNCT06412224 - Phase 1Taking peopleGene Therapy for Diabetic Macular Edema
- Where
- Tianjin
- Age
- 18 years and over
- People
- 18
- Run by
- Frontera Therapeutics
See details and how to joinNCT05916391